TNS2 has been shown to dephosphorylate the insulin receptor substrate 1 (IRS-1) and decrease its activation [20], which in turn can lead to increased interaction between PI3K and PDGFRA, and thus, increased tumor growth [34]. This evidence concerns the gene PDGFRA and neoplasm.